Measuring metabolomics in acute lung injury: choosing the correct compartment?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.Annals of translational medicine · 2017
   Review
2. Postinjury Inflammation and Organ Dysfunction.Critical care clinics · 2017
   Review
3. Metabolomics and Its Application to Acute Lung Diseases.Frontiers in immunology · 2016
   Review
4. Exhaled breath profiling for diagnosing acute respiratory distress syndrome.BMC pulmonary medicine · 2014
   Article
5. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.Journal of proteome research · 2014
   Article

Corrections and comments

• Comment on
  The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses.2011

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as